Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Fluid Restriction Policy Added to Intra-Operative Cell Salvage in Reducing the Use of Red Cells in Cardiac Surgery

NCT00600704 is registered in ClinicalTrials.gov with Larissa University Hospital as lead sponsor.

NCT NCT00600704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00600704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Fluid Restriction Policy Added to Intra-Operative Cell Salvage in Reducing the Use of Red Cells in Cardiac Surgery
Lead sponsor
Larissa University Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2007
Completion date
March 31, 2011
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass, coronary artery disease, erythrocyte transfusion